Thomas D Wang

This inventor holds 26 USPTO granted patents and 18 published patent applications and 2 EPO patents. Top assignees: University of Michigan, Leland Stanford Junior University, Other. Active years: 2012-2026.

USPTO Granted Patents = 26 (Patent Applications = 18)

% Patents Active = 92.3

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 23(Granted Patents)

Location History:

Ann Arbor, MI (US) (2012 - 2023)
Alhambra, CA (US) (2022 - 2024)

Company Filing History:

18 out of 3,519

University of Michigan

patents

1 out of 5,492

Leland Stanford Junior University

patents

5 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697402 - DETECTION OF COLONIC NEOPLASIA IN VIVO USING NEAR-INFRARED PEPTIDE TARGETED AGAINST OVEREXPRESSED CMET (2026-08-04),

2. 12396625 - Ultra-compact microsystems-based single axis confocal endomicroscope (2025-08-26),

3. 12332428 - Comb-driven MEMS resonant scanner with full-circumferential range and large out-of-plane translational displacement (2025-06-17),

4. 12259543 - Ultra-compact folded-beam path confocal endomicroscope (2025-03-25),

5. 12198309 - Phase detection and correction using image-based processing (2025-01-14),

6. D1035531 - Wheel (2024-07-16),

7. 12027263 - Wireless digital treatment and warning system and display for veterinarian animal cages (2024-07-02),

8. D1032492 - Wheel (2024-06-25),

9. D1032452 - Wheel (2024-06-25),

10. D1030596 - Wheel (2024-06-11),

11. D1028857 - Wheel (2024-05-28),

12. 11819310 - 3-axis side-view confocal fluorescence endomicroscope (2023-11-21),

13. 11406720 - Fibroblast growth factor receptor 2-specific peptide reagents and methods (2022-08-09),

14. 11388999 - Lounge cart (2022-07-19),

15. 11248022 - Glypican-3 peptide reagents and methods (2022-02-15),

Couldn't find inventor

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]

18 patents pending:

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]

8 patents pending (EPO):

Please report any incorrect information to [email protected]